| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.5 | 0.07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |